A strong affinity of RP101 to bind to Hsp27 has been detected (directly or indirectly). In different preclinical and clinical studies it has been shown that this interaction can modulate many of the known effects of Hsp27, suggesting the potential role of RP101 in the treatment of many different tumor types.